Hier finden Sie Publikationen unserer Mitarbeiter.

Oncotarget 3 (8): 783-797 (2012-08-07)

Dahlmann M.; Sack U.; Herrmann P.; Lemm M.; Fichtner I.; Schlag P.M.; Stein U.

Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation

Description:
The metastasis-inducing protein S100A4 was found to be a prognostic indicator for the development of metachronous metastases. S100A4 expression levels correlate with the formation of human colorectal cancer metastases and shorter patients' survival. Inhibition of S100A4 expression in patients might therefore result in decreased metastasis formation and prolonged survival. In the present study, we used shRNA expression plasmids to inhibit S100A4 expression in the colorectal cancer cell lines HCT116, SW620 and DLD-1. Cell lines with reduced S100A4 expression showed reduced cell migration and invasion in vitro. The knock-down of S100A4 expression also led to significantly diminished formation of liver metastases when intrasplenically transplanted in mice (P = 0.004). We then focused on the therapeutic potential of systemically applied shRNA expression plasmids acting on S100A4 via repeated hydrodynamics-based tail vein injection of plasmid DNA. Mice, intrasplenically transplanted with HCT116 cells and treated systemically with S100A4‑shRNA plasmids, showed a decrease of S100A4 and MMP9 expression levels, resulting in significantly reduced liver metastases (P = 0.005). In summary, we show for the first time the intratumoral knock down of S100A4 via systemic application of S100A4‑shRNA plasmid DNA, which restricts metastasis formation in a xenografted mouse model of colorectal cancer.

Keywords: Cell Movement, Cell Proliferation, Colorectal Neoplasms, Heterologous Transplantation, Inbred NOD Mice, Liver Neoplasms, Matrix Metalloproteinase 9, Neoplasm Invasiveness, Neoplasm Metastasis, RNA Interference, S100 Proteins, SCID Mice, Small Interfering RNA, Tumor Cell Line, Animals, Mice

Type: Article

PubMed: 22878175
Official URL: https://doi.org/10.18632/oncotarget.572
MDC Repository: https://edoc.mdc-berlin.de/12516/